decisionhealth Newsletters, Part B News - 2004 Issue 3 (March)
Higher Payments for 9 Drugs
Subscribe or sign in to view the full article.
Article Overview
This article explains Medicare payment updates for a group of covered drugs, effective April 1, and places those changes in the context of CMS review authority under the Medicare Prescription Drug, Improvement and Modernization Act. It is relevant for billing staff, coders, and reimbursement professionals who track Part B drug pricing updates, CMS transmittals, and payment-limit revisions for office-administered medications.
Why This Topic Matters
The piece helps readers understand which covered drugs had Medicare payment changes, when the changes took effect, and what CMS policy process drove the updates. That makes it useful for organizations that bill physician-administered drugs and need to monitor reimbursement impacts and source guidance.
Article Sections
-
Payments boosted for 9 covered drugs beginning in April
Introduces the policy update and summarizes why certain drug payments changed beginning April 1. Provides the broad Medicare and CMS context for the reimbursement adjustments.
-
Medicare drug reimbursement increases effective April 1
Presents the payment update table and associated source notes for the drugs discussed in the article. Covers the reimbursement period, claims data context, and the referenced CMS manual transmittal.
What You Will Learn
- How CMS policy changes affected Medicare payments for a group of covered drugs
- What general categories of drugs were included in the update
- How the article frames the timing and source of the payment changes
- Which CMS guidance source is referenced for the reimbursement update
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle professionals
- Practice managers
- Reimbursement specialists
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com